Who is sponsoring NCT06913400?

NCT06913400 is sponsored by Superior University.

What drugs are being tested in NCT06913400?

Interventions in NCT06913400: Stereopsis Recovery.

What condition does NCT06913400 study?

NCT06913400 studies Strabismic Amblyopia, Bilateral.

Is NCT06913400 still recruiting?

NCT06913400 is currently active, enrolled. Last updated 6 April 2025.

Last reviewed 2025-04-06 · How we verify

NCT06913400

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Progression of Stereopsis Recovery in Strabismic Patients: A One-Month and Three-Month Post-Surgery Evaluation

Active, enrolled Last updated 6 April 2025

What this trial tests

trial testing Stereopsis Recovery in Strabismic Amblyopia, Bilateral in 34 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

20 March 2025

Primary endpoint
20 June 2025

20 February 2026

Quick facts

Lead sponsor	Superior University
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	34
Start date	20 March 2025
Primary completion	20 June 2025
Estimated completion	20 February 2026
Sites	1 location across Pakistan

Drugs / interventions tested

Stereopsis Recovery

Conditions studied

Strabismic Amblyopia, Bilateral — all drugs for Strabismic Amblyopia, Bilateral →

Sponsor

Superior University

Who can join

5 and older, any sex, with Strabismic Amblyopia, Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective longitudinal observational study aims to assess stereopsis recovery in strabismic patients at one month and three months post-corrective surgery. The study will be conducted at Mayo Hospital, Lahore, and Sajjad Eye Center, Burewala, with a sample size of 34 using a purposive sampling technique. Eligible participants include patients aged ≥5 years undergoing strabismus surgery for esotropia, exotropia, or vertical deviations, with best-corrected visual acuity (BCVA) of 6/12 in both eyes. Patients with previous strabismus surgery, amblyopia, neurological conditions, or sensory strabismus will be excluded.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Superior University trials

Trials by the same sponsor.

NCT07521839 — Title of This Study is to Evaluate the Effects of Abdominal Drawing in Maneuver With Cross Pattern Limb Exercises in Pat · NA · active not recruiting
NCT07523425 — Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation · NA · recruiting
NCT07068347 — Comparison Of VR & CPT, With And Without Lifestyle Modification, On ULD In Breast Cancer Survivors · NA · active not recruiting
NCT07336459 — AI-Driven MRF Type 2 Diabetes Integrating DHT IF and Resistance Training to OM and Functional Outcomes · NA · active not recruiting
NCT07385066 — Effects of (tDCS) Combined With Virtual Reality Versus CPT on Brain, Cognitive, and GMS in Children With DS. · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06913400 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Superior University
Last refreshed: 6 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06913400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing